Notice of Update to PAR-18-007, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)"
PAR-18-007
NOT-OD-17-062
93.840
Cheryl Boyce, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: [email protected]
Notice Number: NOT-HL-18-618
Key Dates
Release Date: April 9, 2018
PAR-18-007
NOT-OD-17-062
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants that the NHLBI Center for Translation Research and Implementation Science, is participating in PAR-18-007, "Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)." The following changes have been made to reflect NHLBI's participation in this FOA:
Part 1. Overview Information
Catalog of Federal Domestic Assistance (CFDA) Number(s) The following CFDA number has been added to the FOA:93.840
Section VII. Agency Contacts
Scientific/Research Contact(s)
The following contact has been added to the FOA:Cheryl Boyce, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: [email protected]
Inquiries
Please direct all inquiries to:
Department of Health
and Human Services (HHS)
and Human Services (HHS)
